Transplant Oncology: A Frontier in Multidisciplinary Cancer Care

— —

Maen A. Abdelrahim, MD, PhD, Pharm.B (Houston Methodist, Section, Chief Gastrointestinal Medical Oncology, Medical Director Cockrell Center for Advanced Therapeutics (CCAT), Houston, TX, USA)

Transplant Oncology

A Frontier in Multidisciplinary Cancer Care

Maen A. Abdelrahim, MD, PhD, Pharm.B (Houston Methodist, Section, Chief Gastrointestinal Medical Oncology, Medical Director Cockrell Center for Advanced Therapeutics (CCAT), Houston, TX, USA)

$308.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
08 November 2024

Oncology; Transplant surgery

*
*Selected for 2025 Doody’s Core Titles® in Transplantation Surgery
*
*

Transplant Oncology: A Frontier in Multidisciplinary Cancer Care summarizes new and evolving scientific findings and discoveries in the field of cancer and transplants and gives guidance on future directions and related research. With a strong focus on transplant oncology, the book examines new and evolving topics, including the utilization of immunotherapy in special patient populations as well as the clinical updates on new concepts in the field such as using circulating tumor DNA (ctDNA) as a tool for minimal disease detection, surveillance, and treatment response evaluation as well as rejection assessment and detection in transplant patient for oncological indications.

Sections cover applications of transplant medicine and surgery in oncology to improve patient survival outcome and quality of life. The book gives insight into anticancer strategies, such as initiating studies in genomics and cancer immunogenomics based on new insights in liver cancer. In addition, it describes how the adoption of surgical transplantation techniques in oncology has improved conventional resection and bridged the gap between tumor and transplant immunology. This is a must have reference for all those that want to be familiar and up-to-date with the dynamic changes in the field including practicing physicians, scientists, and trainees.

Edited by: Maen A. Abdelrahim MD PhD Pharm.B (Houston Methodist Section Chief Gastrointestinal Medical Oncology Medical Director Cockrell Center for Advanced Therapeutics (CCAT) Houston TX USA)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 276mm, Width: 216mm,
Weight: 970g
ISBN: 9780443219016
ISBN 10: 044321901X
Pages: 360
Publication Date: 08 November 2024
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Dr. Abdelrahim is a gastrointestinal medical oncologist and transplant oncologist with unique experience in malignancies treated by liver transplantation. He is the section chief of GI medical oncology at Houston Methodist Neal Cancer Center. He is heavily involved in the transplant oncology field and have been one of the pioneers in the field. He has published more than 230 original research articles, review articles, and book chapters in prestigious journals and publishing groups. He is a member of the American Society of Clinical Oncology, Society for Immunotherapy of Cancer, Cholangiocarcinoma Foundation, European Society for Medical Oncology, and International Liver Transplant Society